Gone down now?

Azign Bioscience A/S sells licensing rights and focuses its strategy on genomic technologies for the development of drugs and diagnostics

28 May 2001 



http://ns.net.dynamicweb.dk/Default.aspx?ID=489&M=News&PID=2914&NewsID=14720